The recent development of an 18-gene urine test, known as MyProstateScore 2.0 (MPS2), represents a significant advancement in the detection of high-grade prostate cancer. This test has demonstrated higher diagnostic accuracy compared to existing biomarker tests and has the potential to reduce...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.